SMAD2 and Alzheimer disease: Although gene array analysis revealed increased mRNA expression of TGFβ and Smad2/3 in AD cells compared to AI cells (Table S1), western blot analysis showed no activation of the TGFβ/Smad2/3 pathway in the AD cells (Figure 7C).